Torula yeast protein effects on stool and gut health in Labradors

Abstract

This study examined the effects of varying protein sources on apparent total tract digestibility, inflammatory markers, and fecal microbiota in Labrador Retrievers with historically poor stool quality. Thirty dogs (15 male, 15 female; aged 0.93 to 11.7 yr) with stool quality scores &#x2264;2.5 on a 5-point scale (1 representing liquid stool and 5 representing firm stool) were randomly assigned to 1 of 3 nutritionally complete diets with differing protein sources and similar macronutrient profiles: 1) chicken meal (n&#x2005;=&#x2005;10); 2) 10% brewer's yeast (n&#x2005;=&#x2005;10); or 3) 10% torula yeast (n&#x2005;=&#x2005;10). Another 10 dogs (five male, five female) with normal stool quality (scores ranging from 3 to 4) received diet 1 and served as negative control (NC). All dogs were fed diet 1 for 7 days, then provided their assigned treatment diets from days 7 to 37. Daily stool scores and weekly body weights were recorded. On days 7, 21, and 36, blood serum was analyzed for c-reactive protein (CRP), and feces for calgranulin C (S100A12), &#x3b1;1-proteinase inhibitor (&#x3b1;1-PI), calprotectin, and microbiota dysbiosis index. Apparent total tract digestibility was assessed using the indicator method with 2&#xa0;g titanium dioxide administered via oral capsules. Stool scores were greater in NC (P&#x2005;<&#x2005;0.01) as designed but not affected by treatment&#x2005;&#xd7;&#x2005;time interaction (P&#x2005;=&#x2005;0.64). Body weight was greater (P&#x2005;=&#x2005;0.01) and CRP lower (P&#x2005;<&#x2005;0.01) in NC dogs. Dry matter and nitrogen-free extract digestibility did not differ among groups (P&#x2005;&#x2265;&#x2005;0.14). Negative controls had greater fat digestibility compared to BY (94.64&#x2005;&#xb1;&#x2005;1.33% vs. 91.65&#x2005;&#xb1;&#x2005;1.25%; P&#x2005;=&#x2005;0.02). The overall effect of treatment was significant for protein digestibility (P&#x2005;=&#x2005;0.03), but there were no differences in individual post hoc comparisons (P&#x2005;&#x2265;&#x2005;0.07). Treatment did not affect S100A12 or &#x3b1;1-PI (P&#x2005;&#x2265;&#x2005;0.44). Calprotectin decreased at a greater rate over time in TY (P&#x2005;<&#x2005;0.01). The dysbiosis index score for BY and TY fluctuated less over time (P&#x2005;=&#x2005;0.01). Blautia (P&#x2005;=&#x2005;0.03) and Clostridium hiranonis (P&#x2005;=&#x2005;0.05) abundances were reduced in BY and TY. Dogs with chronically poor stool quality experienced reduced body weights and increased serum CRP, but TY numerically increased protein digestibility, altered the microbiome, and reduced fecal calprotectin. Torula yeast is a suitable alternative protein source in extruded canine diets, but further research is needed to understand the long-term potential for improving the plane of nutrition and modulating gut health.